// App-Quantinova.ai

9029 : Meta-analysis exploring the effect of oncogenic driver mutations on outcome of metastatic non-small cell lung cancer (mNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICI) or docetaxel (doc).

Researchers

Presenter

  • Abena Agyeman

Principal Investigators

  • Jonathon Joseph Vallejo

  • Adrian Myers

  • Gideon Michael Blumenthal

Medical Centers

  • U.S. Food and Drug Administration, Silver Spring, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Programmed death-ligand 1

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • Docetaxel

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved